Intra-patient dose escalation of panobinostat in patients with relapsed/refractory multiple myeloma

Leuk Lymphoma. 2018 May;59(5):1277-1278. doi: 10.1080/10428194.2017.1372579. Epub 2017 Sep 6.
No abstract available

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bortezomib / administration & dosage
  • Dexamethasone / administration & dosage
  • Dose-Response Relationship, Drug
  • Drug Resistance, Neoplasm / drug effects*
  • Humans
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology
  • Panobinostat / administration & dosage
  • Prognosis
  • Retrospective Studies
  • Salvage Therapy*

Substances

  • Bortezomib
  • Dexamethasone
  • Panobinostat